These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20014068)
1. Resveratrol derivative, trans-3,5,4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation. Alex D; Leong EC; Zhang ZJ; Yan GT; Cheng SH; Leong CW; Li ZH; Lam KH; Chan SW; Lee SM J Cell Biochem; 2010 Feb; 109(2):339-46. PubMed ID: 20014068 [TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. Belleri M; Ribatti D; Nicoli S; Cotelli F; Forti L; Vannini V; Stivala LA; Presta M Mol Pharmacol; 2005 May; 67(5):1451-9. PubMed ID: 15703378 [TBL] [Abstract][Full Text] [Related]
3. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo. Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746 [TBL] [Abstract][Full Text] [Related]
4. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Nicoli S; Ribatti D; Cotelli F; Presta M Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396 [TBL] [Abstract][Full Text] [Related]
5. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466 [TBL] [Abstract][Full Text] [Related]
6. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Jung MH; Lee SH; Ahn EM; Lee YM Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells. Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539 [TBL] [Abstract][Full Text] [Related]
8. Angiogenic efficacy of simplified 2-herb formula (NF3) in zebrafish embryos in vivo and rat aortic ring in vitro. Tse HY; Hui MN; Li L; Lee SM; Leung AY; Cheng SH J Ethnopharmacol; 2012 Jan; 139(2):447-53. PubMed ID: 22138660 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523 [TBL] [Abstract][Full Text] [Related]
10. Effect of proton beam on blood vessel formation in early developing zebrafish (Danio rerio) embryos. Jang GH; Ha JH; Huh TL; Lee YM Arch Pharm Res; 2008 Jun; 31(6):779-85. PubMed ID: 18563361 [TBL] [Abstract][Full Text] [Related]
11. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. Lam HW; Lin HC; Lao SC; Gao JL; Hong SJ; Leong CW; Yue PY; Kwan YW; Leung AY; Wang YT; Lee SM J Cell Biochem; 2008 Jan; 103(1):195-211. PubMed ID: 17497682 [TBL] [Abstract][Full Text] [Related]
12. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of quercetin on angiogenesis in larval zebrafish and human umbilical vein endothelial cells. Zhao D; Qin C; Fan X; Li Y; Gu B Eur J Pharmacol; 2014 Jan; 723():360-7. PubMed ID: 24239714 [TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor. Morais C; Gobe G; Johnson DW; Healy H Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. Browne CD; Hindmarsh EJ; Smith JW FASEB J; 2006 Oct; 20(12):2027-35. PubMed ID: 17012255 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells. Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835 [TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells. Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]